Wednesday met Wall Street's fourth-quarter earnings estimates and forecast slightly weaker-than-expected earnings for 2001.
The company best known for the anti-impotence pill
reported sturdy earnings of 27 cents per share, or $1.78 billion, matching the consensus estimate of 26 Wall Street analysts polled by
First Call/Thomson Financial
. In the same quarter a year ago, the company earned $1.47 billion, or 23 cents a share.
New York-based Pfizer said its results were lifted by sales of its anti-cholesterol drug
and arthritis drug
For 2001, the company expects to earn $1.27 a share, 3 cents shy of the consensus estimate.
Pfizer's stock was recently trading down slightly at $42.06 in pre-market
trading, having closed at $42.88 Tuesday on the
New York Stock Exchange